external-file_edited (1)_edited_edited_edited_edited.png

Hello.

Welcome to BioFocus.
Explore the latest updates from the life science industry.

PHARMA

Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Despite positive long-term efficacy and safety data, the biopharma has concluded its OX40L antibody would not offer a meaningful improvement over current standards of care and will no longer pursue regulatory approval for the indication.

Featured Articles.

PHARMA

How Automation is Accelerating Drug Discovery Timelines

BIOTECH

Tecan Brings Agentic AI to the Lab Bench with NVIDIA-powered Introspect Upgrade

PHARMA

AI in Science Writing and the Imitation of Understanding

PHARMA

Pharma Smart Manufacturing 2026

HEALTH

A New Device Could Improve How Progesterone is Delivered in Early Pregnancy

BIOTECH

Moving research out of the lab is key to UK life science success

BIOTECH

Basecamp Research Launches the Trillion Gene Atlas

BIOPROCESSING

Bioreactors and Cell Culture Media: A Practical Comparison for Upstream Bioprocessing

HEALTH

The Risk AI Poses to Public Health

BIOTECH

UK Biotech Cyclana Bio is Trying to Understand Endometriosis From the Tissue Up and it's Just Recruited its First Patients

Latest News.

24th July, 2026

01. Sanofi halts amlitelimab development for atopic dermatitis following pipeline review

Despite positive long-term efficacy and safety data, the biopharma has concluded its OX40L antibody would not offer a meaningful improvement over current standards of care and will no longer pursue regulatory approval for the indication.

21st July, 2026

02. Kolon TissueGene's Knee Osteoarthritis Therapy Fails Phase 3 Trial

Second late-stage study due in October will decide the fate of the cell-based gene therapy programme.

17th July, 2026

03. Hummingbird Bioscience wins APAC AI Discovery Award

Singapore-based Hummingbird Bioscience has been named the Asia Pacific Trailblazer Award winner at the 2026 Nebius AI Discovery Awards, recognising the company's AI-first approach to therapeutic discovery and development.

13th July, 2026

04. ABM secures major multi-site contract supporting Ireland’s manufacturing sector

Facilities and engineering provider strengthens presence in regulated environments with technology-enabled approach to compliance and operational support